Search Results - "Hamed, Kamal A"

Refine Results
  1. 1

    Safety and pharmacokinetics of SPR206 in subjects with varying degrees of renal impairment by Bruss, Jon B, Bader, Justin, Hamed, Kamal A

    Published in Antimicrobial agents and chemotherapy (15-11-2023)
    “…SPR206 is a novel polymyxin derivative with potent activity against susceptible and multidrug-resistant strains of , , , , and species. SPR206 is eliminated…”
    Get full text
    Journal Article
  2. 2

    Efficacy of SPR720 in murine models of non-tuberculous mycobacterial pulmonary infection by Cotroneo, Nicole, Stokes, Suzanne S, Pucci, Michael J, Rubio, Aileen, Hamed, Kamal A, Critchley, Ian A

    Published in Journal of antimicrobial chemotherapy (02-04-2024)
    “…Non-tuberculous mycobacterial pulmonary disease (NTM-PD) is increasing worldwide, with Mycobacterium avium complex (MAC) and Mycobacterium abscessus as the…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6

    Ceftobiprole Activity against Bacteria from Skin and Skin Structure Infections in the United States from 2016 through 2018 by Flamm, Robert K, Duncan, Leonard R, Hamed, Kamal A, Smart, Jennifer I, Mendes, Rodrigo E, Pfaller, Michael A

    Published in Antimicrobial agents and chemotherapy (21-05-2020)
    “…Ceftobiprole medocaril is an advanced-generation cephalosporin prodrug that has qualified infectious disease product status granted by the US FDA and is…”
    Get full text
    Journal Article
  7. 7

    Ceftobiprole Activity against Gram-Positive and -Negative Pathogens Collected from the United States in 2006 and 2016 by Pfaller, Michael A, Flamm, Robert K, Mendes, Rodrigo E, Streit, Jennifer M, Smart, Jennifer I, Hamed, Kamal A, Duncan, Leonard R, Sader, Helio S

    Published in Antimicrobial agents and chemotherapy (01-01-2019)
    “…Ceftobiprole is an advanced cephalosporin with potent activity against Gram-positive and Gram-negative bacteria that has been approved in many European and…”
    Get full text
    Journal Article
  8. 8

    Ceftobiprole activity against Gram-positive and Gram-negative pathogens causing bone and joint infections in the United States from 2016 to 2020 by Duncan, Leonard R., Hamed, Kamal A., Smart, Jennifer I., Pfaller, Michael A., Flamm, Robert K., Mendes, Rodrigo E.

    “…Bone and joint infections (BJIs) present significant treatment challenges. Ceftobiprole, a broad-spectrum cephalosporin with activity against…”
    Get full text
    Journal Article
  9. 9

    Ceftobiprole activity when tested against contemporary bacteria causing bloodstream infections in the United States (2016–2017) by Pfaller, Michael A., Flamm, Robert K., Duncan, Leonard R., Shortridge, Dee, Smart, Jennifer I., Hamed, Kamal A., Mendes, Rodrigo E., Sader, Helio S.

    “…Ceftobiprole medocaril, the prodrug of ceftobiprole, is an advanced-generation cephalosporin that is approved in many European and non-European countries for…”
    Get full text
    Journal Article
  10. 10

    Evaluation of Factors Predictive of Efficacy Among Patients With Complicated Urinary Tract Infection and/or Acute Pyelonephritis by Bhavnani, Sujata M, Hammel, Jeffrey P, Rubino, Christopher M, Talley, Angela K, Eckburg, Paul B, Liolios, Kathryn, Gupta, Vipul K, Ambrose, Paul G, Hamed, Kamal A, Melnick, David A

    Published in Open forum infectious diseases (01-09-2024)
    “…Abstract Background Antibiotic treatment for complicated urinary tract infections (cUTI)/acute pyelonephritis (AP) is often followed by recurrent bacteriuria…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Randomized, Investigator-Blinded, Multicenter Study of Gatifloxacin Versus Amoxicillin/Clavulanate Treatment of Recurrent and Nonresponsive Otitis Media in Children by Sáez-Llorens, Xavier, Rodriguez, Adib, Arguedas, Adriano, Hamed, Kamal A, Yang, Joanna, Pierce, Phillip, Echols, Roger

    Published in The Pediatric infectious disease journal (01-04-2005)
    “…BACKGROUND:Decreased susceptibility of pathogens to currently used agents for recurrent otitis media has provided the impetus for identifying new antimicrobial…”
    Get full text
    Journal Article
  14. 14

    Comparison of once-daily extended-release ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in women by Henry, Dan C., Bettis, Robert B., Riffer, Ernie, Haverstock, Daniel C., Kowalsky, Steven F., Manning, Kathryn, Hamed, Kamal A., Church, Deborah A.

    Published in Clinical therapeutics (01-12-2002)
    “…Background: Trimethoprim/sulfamethoxazole (TMP/SMX) is currently the first choice for empiric therapy of acute uncomplicated urinary tract infection (UTI) in…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    Kaposi's sarcoma of the breast by Hamed, K A, Muller, K E, Nawab, R A

    Published in AIDS patient care and STDs (01-02-2000)
    “…Kaposi's sarcoma of the breast is extremely rare. We report a case of a patient with AIDS presenting with Kaposi's sarcoma localized to the breast and review…”
    Get more information
    Journal Article
  19. 19

    Haemophilus parainfluenzae Endocarditis: Application of a Molecular Approach for Identification of Pathogenic Bacterial Species by Hamed, Kamal A., Dormitzer, Philip R., Su, Catherine K., Relman, David A.

    Published in Clinical infectious diseases (01-10-1994)
    “…Haemophilus parainfluenzae is both a human oropharyngeal commensal bacterium and a cause of serious invasive disease. The fastidious growth characteristics of…”
    Get full text
    Journal Article
  20. 20

    Pulmonary mucormycosis presenting as an endobronchial lesion by Husari, A W, Jensen, W A, Kirsch, C M, Campagna, A C, Kagawa, F T, Hamed, K A, Azzi, R L, Stevens, D A

    Published in Chest (01-12-1994)
    “…A 56-year-old diabetic man presented with left upper lobe collapse and postobstructive pneumonitis. Fiberoptic bronchoscopy revealed an endobronchial mass…”
    Get more information
    Journal Article